Related Experiment Video
Updated: May 16, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
Food Insecurity and Clinical Biomarkers of Inflammation among Cancer Survivors in the All of Us Research Program
Cecily A Byrne1, Sage J Kim2, Greg Kopetsky2
1University of Illinois Chicago, Cancer Health Equity and Career Development Program, Chicago, Illinois.
Background:
Food insecurity is associated with a 40% increase in the prevalence of chronic conditions, including cancer. Stress-evoked inflammation is a hypothesized mechanism driving these associations. This study tested the association between food insecurity and inflammation in cancer survivors.
Methods:
Our sample included individuals with a history of lung, breast, prostate, and colorectal cancers from the All of Us Research Program. Food insecurity was measured using validated questions, and inflammatory biomarkers were obtained from electronic health records (EHR). Our primary analysis tested the association between food insecurity and C-reactive protein (CRP; n = 413) using multivariable regression models, controlling for sociodemographics and current cancer treatment.
Results:
The primary cohort was 69.8 ± 9.5 years in age, 61.0% female, 89.3% non-Hispanic White, and 9.9% had food insecurity. A higher proportion of racial/ethnic minorities (40.8%) and individuals with lower annual household income (33.3%) and education (29.4%) had food insecurity. The mean CRP was higher among those with food insecurity (14.5 ± 18.5) than among food-secure individuals (10.4 ± 17.8), but it was not significantly associated with CRP in our fully adjusted models.
Conclusions:
Lung, breast, prostate, and colorectal cancer survivors had moderate levels of inflammation measured by CRP; however, food insecurity was not associated with CRP in fully adjusted models.
Impact:
In this cohort, there was no association between food insecurity and CRP; however, given that food insecurity and inflammation are plausible contributors to chronic disease, future studies should include underrepresented survivors with EHR data and a broader range of cancers.
More Related Videos
03:35Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography
Published on: December 1, 2023
07:20Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Related Concept Videos
Cancer Prevention
Some...
Cancer Survival Analysis
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Psychoneuroimmunology: Diabetes and Cancer
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...